TY - BOOK AU - Bush, A. AU - Bilton, D. AU - Hodson, M. PY - 2015 DA - 2015// TI - Hodson and Geddes’ cystic fibrosis PB - CRC Press CY - Hoboken UR - https://doi.org/10.1201/b18629 DO - 10.1201/b18629 ID - Bush2015 ER - TY - JOUR AU - Marson, F. A. L. AU - Bertuzzo, C. S. AU - Ribeiro, J. D. PY - 2016 DA - 2016// TI - Classification of CFTR mutation classes JO - Lancet Respir Med VL - 4 UR - https://doi.org/10.1016/S2213-2600(16)30188-6 DO - 10.1016/S2213-2600(16)30188-6 ID - Marson2016 ER - TY - JOUR AU - Schechter, M. S. PY - 2003 DA - 2003// TI - Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions JO - Semin Respir Crit Care Med VL - 24 UR - https://doi.org/10.1055/s-2004-815660 DO - 10.1055/s-2004-815660 ID - Schechter2003 ER - TY - JOUR AU - Salvatore, F. AU - Scudiero, O. AU - Castaldo, G. PY - 2002 DA - 2002// TI - Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes JO - Am J Med Genet VL - 111 UR - https://doi.org/10.1002/ajmg.10461 DO - 10.1002/ajmg.10461 ID - Salvatore2002 ER - TY - JOUR AU - Mekus, F. AU - Ballmann, M. AU - Bronsveld, I. AU - Bijman, J. AU - Veeze, H. AU - Tümmler, B. PY - 2000 DA - 2000// TI - Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics JO - Twin Res VL - 3 UR - https://doi.org/10.1375/136905200320565256 DO - 10.1375/136905200320565256 ID - Mekus2000 ER - TY - JOUR AU - Waller, M. D. AU - Simmonds, N. J. PY - 2016 DA - 2016// TI - Phenotypic variability of R117H-CFTR expression within monozygotic twins JO - Paediatr Respir Rev VL - 20 UR - https://doi.org/10.1016/j.prrv.2016.06.009 DO - 10.1016/j.prrv.2016.06.009 ID - Waller2016 ER - TY - JOUR AU - Farrell, P. M. AU - White, T. B. AU - Ren, C. L. AU - Hempstead, S. E. AU - Accurso, F. AU - Derichs, N. PY - 2017 DA - 2017// TI - Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation JO - J Pediatr VL - 181S UR - https://doi.org/10.1016/j.jpeds.2016.09.064 DO - 10.1016/j.jpeds.2016.09.064 ID - Farrell2017 ER - TY - JOUR AU - Dean, M. AU - White, M. B. AU - Amos, J. AU - Gerrard, B. AU - Stewart, C. AU - Khaw, K. -. T. AU - Leppert, M. PY - 1990 DA - 1990// TI - Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients JO - Cell. VL - 61 UR - https://doi.org/10.1016/0092-8674(90)90196-L DO - 10.1016/0092-8674(90)90196-L ID - Dean1990 ER - TY - JOUR AU - Sheppard, D. N. AU - Rich, D. P. AU - Ostedgaard, L. S. AU - Gregory, R. J. AU - Smith, A. E. AU - Welsh, M. J. PY - 1993 DA - 1993// TI - Mutations in CFTR associated with mild-disease-form cl- channels with altered pore properties JO - Nature. VL - 362 UR - https://doi.org/10.1038/362160a0 DO - 10.1038/362160a0 ID - Sheppard1993 ER - TY - STD TI - Nährlich L., Burkhart M., Wiese B.. German cystic fibrosis register. https://www.muko.info/fileadmin/user_upload/angebote/qualitaetsmanagement/register/annual_report_2016.pdf. Accessed 02 Apr 2019. UR - https://www.muko.info/fileadmin/user_upload/angebote/qualitaetsmanagement/register/annual_report_2016.pdf ID - ref10 ER - TY - STD TI - Cystic Fibrosis Foundation Patient Registry. 2016 Patient Registry Annual Data Report. https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdf. Accessed 02 Apr 2019. UR - https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2016-Patient-Registry-Annual-Data-Report.pdf ID - ref11 ER - TY - JOUR AU - Thauvin-Robinet, C. AU - Munck, A. AU - Huet, F. AU - Génin, E. AU - Bellis, G. AU - Gautier, E. PY - 2009 DA - 2009// TI - The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening JO - J Med Genet VL - 46 UR - https://doi.org/10.1136/jmg.2009.067215 DO - 10.1136/jmg.2009.067215 ID - Thauvin-Robinet2009 ER - TY - JOUR AU - Kiesewetter, S. AU - Macek, M. AU - Davis, C. AU - Curristin, S. M. AU - Chu, C. S. AU - Graham, C. PY - 1993 DA - 1993// TI - A mutation in CFTR produces different phenotypes depending on chromosomal background JO - Nat Genet VL - 5 UR - https://doi.org/10.1038/ng1193-274 DO - 10.1038/ng1193-274 ID - Kiesewetter1993 ER - TY - JOUR AU - Keenan, K. a. t. h. e. r. i. n. e. AU - Dupuis, A. n. n. i. e. AU - Griffin, K. a. t. h. e. r. i. n. e. AU - Castellani, C. a. r. l. o. AU - Tullis, E. l. i. z. a. b. e. t. h. AU - Gonska, T. a. n. j. a. PY - 2019 DA - 2019// TI - Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His JO - Journal of Cystic Fibrosis VL - 18 UR - https://doi.org/10.1016/j.jcf.2018.09.002 DO - 10.1016/j.jcf.2018.09.002 ID - Keenan2019 ER - TY - JOUR AU - Noone, P. G. AU - Pue, C. A. AU - Zhou, Z. AU - Friedman, K. J. AU - Wakeling, E. L. AU - Ganeshananthan, M. PY - 2000 DA - 2000// TI - Lung disease associated with the IVS8 5T allele of the CFTR gene JO - Am J Respir Crit Care Med VL - 162 UR - https://doi.org/10.1164/ajrccm.162.5.2003160 DO - 10.1164/ajrccm.162.5.2003160 ID - Noone2000 ER - TY - JOUR AU - Peckham, D. AU - Conway, S. P. AU - Morton, A. AU - Jones, A. AU - Webb, K. PY - 2006 DA - 2006// TI - Delayed diagnosis of cystic fibrosis associated with R117H on a background of 7T polythymidine tract at intron 8 JO - J Cyst Fibros VL - 5 UR - https://doi.org/10.1016/j.jcf.2005.09.009 DO - 10.1016/j.jcf.2005.09.009 ID - Peckham2006 ER - TY - JOUR AU - O'Sullivan, B. P. AU - Zwerdling, R. G. AU - Dorkin, H. L. AU - Comeau, A. M. AU - Parad, R. PY - 2006 DA - 2006// TI - Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype JO - Pediatrics. VL - 118 UR - https://doi.org/10.1542/peds.2006-0399 DO - 10.1542/peds.2006-0399 ID - O'Sullivan2006 ER - TY - JOUR AU - Ramsey, B. W. AU - Davies, J. AU - McElvaney, N. G. AU - Tullis, E. AU - Bell, S. C. AU - Dřevínek, P. PY - 2011 DA - 2011// TI - A CFTR potentiator in patients with cystic fibrosis and the G551D mutation JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1105185 DO - 10.1056/NEJMoa1105185 ID - Ramsey2011 ER - TY - JOUR AU - Goor, F. AU - Yu, H. AU - Burton, B. AU - Hoffman, B. J. PY - 2014 DA - 2014// TI - Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function JO - J Cyst Fibros VL - 13 UR - https://doi.org/10.1016/j.jcf.2013.06.008 DO - 10.1016/j.jcf.2013.06.008 ID - Goor2014 ER - TY - JOUR AU - Moss, R. B. AU - Flume, P. A. AU - Elborn, J. S. AU - Cooke, J. AU - Rowe, S. M. AU - McColley, S. A. PY - 2015 DA - 2015// TI - Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial JO - Lancet Respir Med VL - 3 UR - https://doi.org/10.1016/S2213-2600(15)00201-5 DO - 10.1016/S2213-2600(15)00201-5 ID - Moss2015 ER - TY - JOUR AU - Gallati, S. PY - 2014 DA - 2014// TI - Disease-modifying genes and monogenic disorders: experience in cystic fibrosis JO - Appl Clin Genet VL - 7 UR - https://doi.org/10.2147/TACG.S18675 DO - 10.2147/TACG.S18675 ID - Gallati2014 ER - TY - JOUR AU - Guillot, L. AU - Beucher, J. AU - Tabary, O. AU - Rouzic, P. AU - Clement, A. AU - Corvol, H. PY - 2014 DA - 2014// TI - Lung disease modifier genes in cystic fibrosis JO - Int J Biochem Cell Biol VL - 52 UR - https://doi.org/10.1016/j.biocel.2014.02.011 DO - 10.1016/j.biocel.2014.02.011 ID - Guillot2014 ER - TY - JOUR AU - Marson, F. A. L. PY - 2018 DA - 2018// TI - Disease-modifying genetic factors in cystic fibrosis JO - Curr Opin Pulm Med VL - 24 UR - https://doi.org/10.1097/MCP.0000000000000479 DO - 10.1097/MCP.0000000000000479 ID - Marson2018 ER - TY - JOUR AU - Wirth, B. AU - Garbes, L. AU - Riessland, M. PY - 2013 DA - 2013// TI - How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches JO - Curr Opin Genet Dev VL - 23 UR - https://doi.org/10.1016/j.gde.2013.03.003 DO - 10.1016/j.gde.2013.03.003 ID - Wirth2013 ER - TY - JOUR AU - Rodman, D. M. AU - Polis, J. M. AU - Heltshe, S. L. AU - Sontag, M. K. AU - Chacon, C. AU - Rodman, R. V. PY - 2005 DA - 2005// TI - Late diagnosis defines a unique population of long-term survivors of cystic fibrosis JO - Am J Respir Crit Care Med VL - 171 UR - https://doi.org/10.1164/rccm.200403-404OC DO - 10.1164/rccm.200403-404OC ID - Rodman2005 ER - TY - JOUR AU - Shteinberg, M. AU - Downey, D. G. AU - Beattie, D. AU - McCaughan, J. AU - Reid, A. AU - Stein, N. AU - Elborn, J. S. PY - 2017 DA - 2017// TI - Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His JO - ERJ Open Res VL - 3 UR - https://doi.org/10.1183/23120541.00056-2016 DO - 10.1183/23120541.00056-2016 ID - Shteinberg2017 ER - TY - JOUR AU - Ren, C. L. AU - Morgan, R. L. AU - Oermann, C. AU - Resnick, H. E. AU - Brady, C. AU - Campbell, A. PY - 2018 DA - 2018// TI - Cystic fibrosis foundation pulmonary guidelines. Use of cystic fibrosis transmembrane conductance regulator modulator therapy in patients with cystic fibrosis JO - Ann Am Thorac Soc VL - 15 UR - https://doi.org/10.1513/AnnalsATS.201707-539OT DO - 10.1513/AnnalsATS.201707-539OT ID - Ren2018 ER - TY - JOUR AU - Feng, L. B. AU - Grosse, S. D. AU - Green, R. F. AU - Fink, A. K. AU - Sawicki, G. S. PY - 2018 DA - 2018// TI - Precision medicine in action: the impact of Ivacaftor on cystic fibrosis-related hospitalizations JO - Health Aff (Millwood) VL - 37 UR - https://doi.org/10.1377/hlthaff.2017.1554 DO - 10.1377/hlthaff.2017.1554 ID - Feng2018 ER - TY - JOUR AU - Wagener, J. e. f. f. r. e. y. S. AU - Millar, S. t. e. f. a. n. i. e. J. AU - Mayer-Hamblett, N. i. c. o. l. e. AU - Sawicki, G. r. e. g. o. r. y. S. AU - McKone, E. d. w. a. r. d. F. AU - Goss, C. h. r. i. s. t. o. p. h. e. r. H. AU - Konstan, M. i. c. h. a. e. l. W. AU - Morgan, W. a. y. n. e. J. AU - Pasta, D. a. v. i. d. J. AU - Moss, R. i. c. h. a. r. d. B. PY - 2018 DA - 2018// TI - Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation JO - Journal of Cystic Fibrosis VL - 17 UR - https://doi.org/10.1016/j.jcf.2017.10.003 DO - 10.1016/j.jcf.2017.10.003 ID - Wagener2018 ER - TY - JOUR AU - Barry, P. J. AU - Plant, B. J. AU - Nair, A. AU - Bicknell, S. AU - Simmonds, N. J. AU - Bell, N. J. PY - 2014 DA - 2014// TI - Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease JO - Chest. VL - 146 UR - https://doi.org/10.1378/chest.13-2397 DO - 10.1378/chest.13-2397 ID - Barry2014 ER - TY - JOUR AU - Hebestreit, H. AU - Sauer-Heilborn, A. AU - Fischer, R. AU - Käding, M. AU - Mainz, J. G. PY - 2013 DA - 2013// TI - Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation JO - J Cyst Fibros VL - 12 UR - https://doi.org/10.1016/j.jcf.2013.05.006 DO - 10.1016/j.jcf.2013.05.006 ID - Hebestreit2013 ER - TY - JOUR AU - Konstan, M. W. AU - Plant, B. J. AU - Elborn, J. S. AU - Rodriguez, S. AU - Munck, A. AU - Ahrens, R. AU - Johnson, C. PY - 2015 DA - 2015// TI - Efficacy response in CF patients treated with ivacaftor: post-hoc analysis JO - Pediatr Pulmonol VL - 50 UR - https://doi.org/10.1002/ppul.23173 DO - 10.1002/ppul.23173 ID - Konstan2015 ER - TY - JOUR AU - Accurso, F. J. AU - Rowe, S. M. AU - Clancy, J. P. AU - Boyle, M. P. AU - Dunitz, J. M. AU - Durie, P. R. PY - 2010 DA - 2010// TI - Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909825 DO - 10.1056/NEJMoa0909825 ID - Accurso2010 ER - TY - JOUR AU - Taylor-Robinson, D. AU - Whitehead, M. AU - Diderichsen, F. AU - Olesen, H. V. AU - Pressler, T. AU - Smyth, R. L. AU - Diggle, P. PY - 2012 DA - 2012// TI - Understanding the natural progression in %FEV 1 decline in patients with cystic fibrosis: a longitudinal study JO - Thorax. VL - 67 UR - https://doi.org/10.1136/thoraxjnl-2011-200953 DO - 10.1136/thoraxjnl-2011-200953 ID - Taylor-Robinson2012 ER - TY - JOUR AU - Corvol, H. AU - Mésinèle, J. AU - Douksieh, I. -. H. AU - Strug, L. J. AU - Boëlle, P. -. Y. AU - Guillot, L. PY - 2018 DA - 2018// TI - SLC26A9 gene is associated with lung function response to Ivacaftor in patients with cystic fibrosis JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.00828 DO - 10.3389/fphar.2018.00828 ID - Corvol2018 ER - TY - JOUR AU - Cirilli, N. AU - Raia, V. AU - Rocco, I. AU - de, G. F. AU - Tosco, A. AU - Salvadori, L. PY - 2018 DA - 2018// TI - Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects JO - Pediatr Pulmonol VL - 53 UR - https://doi.org/10.1002/ppul.23992 DO - 10.1002/ppul.23992 ID - Cirilli2018 ER - TY - JOUR AU - Faria, A. G. AU - Marson, F. A. L. AU - Gomez, C. C. S. AU - Servidoni, M. F. AU - Ribeiro, A. F. AU - Ribeiro, J. D. PY - 2017 DA - 2017// TI - Thirty years of sweat chloride testing at one referral center JO - Front Pediatr VL - 5 UR - https://doi.org/10.3389/fped.2017.00222 DO - 10.3389/fped.2017.00222 ID - Faria2017 ER - TY - JOUR AU - Barry, P. J. AU - Jones, A. M. AU - Webb, A. K. AU - Horsley, A. R. PY - 2014 DA - 2014// TI - Sweat chloride is not a useful marker of clinical response to Ivacaftor JO - Thorax. VL - 69 UR - https://doi.org/10.1136/thoraxjnl-2013-204532 DO - 10.1136/thoraxjnl-2013-204532 ID - Barry2014 ER - TY - JOUR AU - Mesbahi, M. AU - Shteinberg, M. AU - Wilschanski, M. AU - Hatton, A. AU - Nguyen-Khoa, T. AU - Friedman, H. PY - 2017 DA - 2017// TI - Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftor JO - J Cyst Fibros VL - 16 UR - https://doi.org/10.1016/j.jcf.2016.08.006 DO - 10.1016/j.jcf.2016.08.006 ID - Mesbahi2017 ER - TY - JOUR AU - de, B. K. AU - Munck, A. AU - Walker, S. AU - Faro, A. AU - Hiatt, P. AU - Gilmartin, G. AU - Higgins, M. PY - 2014 DA - 2014// TI - Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation JO - J Cyst Fibros VL - 13 UR - https://doi.org/10.1016/j.jcf.2014.09.005 DO - 10.1016/j.jcf.2014.09.005 ID - de2014 ER - TY - JOUR AU - Durmowicz, A. G. AU - Witzmann, K. A. AU - Rosebraugh, C. J. AU - Chowdhury, B. A. PY - 2013 DA - 2013// TI - Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience JO - Chest. VL - 143 UR - https://doi.org/10.1378/chest.12-1430 DO - 10.1378/chest.12-1430 ID - Durmowicz2013 ER - TY - STD TI - Whiting P, Al M, Burgers L, Westwood M, Ryder S, Hoogendoorn M, et al. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2014. https://doi.org/10.3310/hta18180 . ID - ref42 ER - TY - JOUR AU - Dilokthornsakul, P. AU - Hansen, R. N. AU - Campbell, J. D. PY - 2016 DA - 2016// TI - Forecasting US ivacaftor outcomes and cost in cystic fibrosis patients with the G551D mutation JO - Eur Respir J VL - 47 UR - https://doi.org/10.1183/13993003.01444-2015 DO - 10.1183/13993003.01444-2015 ID - Dilokthornsakul2016 ER -